MOMENTA PHARMACEUTICALS INC 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Feb 20, 2015
Insider Transaction Report
Form 4
Franken Michael
President, Biosimilars Busines
Transactions
- Award
Common Stock
2015-02-18+16,976→ 40,025 total - Award
Stock Option (Right to buy)
2015-02-18$13.02/sh+33,953$442,068→ 103,953 totalExercise: $13.02From: 2015-05-18Exp: 2025-02-18→ Common Stock (33,953 underlying)
Footnotes (3)
- [F1]Represents 16,976 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Franken. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 18, 2016 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
- [F2]This balance of shares beneficially owned reflects 96 shares acquired under the employee stock plan at a purchase price of $9.10 per share on January 31, 2015.
- [F3]Represents an option granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria, the shares subject to such option vest as to 6.25% of the shares at the end of each three-month period following the grant date